These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases.
    Author: Zampino R, Vitrone M, Parrella A, Ragone E, Durante-Mangoni E.
    Journal: J Chemother; 2018 Apr; 30(2):129-130. PubMed ID: 28925824.
    Abstract:
    Current interest in HCV therapy with direct acting antivirals is focused on shortening treatment length. We managed two cirrhotics who achieved virological cure after 4 weeks of ombitasvir/paritaprevir/ritonavir, dasabuvir, ribavirin treatment. Analysis to identify potential predictive factors for a successful outcome with a shorter treatment course was conducted.
    [Abstract] [Full Text] [Related] [New Search]